{"entity":{"type":"insider","cik":"0001412377","url":"/insider/0001412377","json_url":"/insider/0001412377.json","name":"Rubin Marc","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":24,"n_filings":17,"first":"2008-02-07","last":"2019-02-25","span_basis":"filed_date"},"name_variants":[{"name":"Rubin Marc","source":"filing","n_filings":17,"first_seen":"2008-02-07","last_seen":"2019-02-25"}],"transactions":[{"id":8187099,"accession":"0001179022-19-000027","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001179022-19-000027","line_url":"/filing/0001179022-19-000027#line-5","is_derivative":false,"issuer_cik":"0001133416","issuer_name":"GALECTIN THERAPEUTICS INC","issuer_ticker":"GALT","issuer_name_source":null,"issuer_url":"/issuer/0001133416","owner_cik":"0001412377","owner_name":"Rubin Marc","owner_display_name":"Rubin Marc","owner_url":"/insider/0001412377","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":859.0,"shares_display":"859","price_per_share":6.0244,"price_display":"6.02","price_state":"stated","total_value":5174.9596,"total_display":"5,174.96","total_whole":"5,175","shares_owned_after":13581.0,"shares_owned_after_display":"13,581","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-02-22","filed_date":"2019-02-25","scope":"insider"},{"id":8187093,"accession":"0001179022-19-000027","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001179022-19-000027","line_url":"/filing/0001179022-19-000027","is_derivative":false,"issuer_cik":"0001133416","issuer_name":"GALECTIN THERAPEUTICS INC","issuer_ticker":"GALT","issuer_name_source":null,"issuer_url":"/issuer/0001133416","owner_cik":"0001412377","owner_name":"Rubin Marc","owner_display_name":"Rubin Marc","owner_url":"/insider/0001412377","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50326.0,"shares_display":"50,326","price_per_share":6.021264400111274,"price_display":"6.02","price_state":"stated","total_value":303026.1522,"total_display":"303,026.15","total_whole":"303,026","shares_owned_after":13581.0,"shares_owned_after_display":"13,581","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-02-21","filed_date":"2019-02-25","scope":"insider","n_lines":2},{"id":8644022,"accession":"0001209191-19-005352","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-005352","line_url":"/filing/0001209191-19-005352#line-1","is_derivative":false,"issuer_cik":"0001108205","issuer_name":"CURIS INC","issuer_ticker":"CRIS","issuer_name_source":null,"issuer_url":"/issuer/0001108205","owner_cik":"0001412377","owner_name":"Rubin Marc","owner_display_name":"Rubin Marc","owner_url":"/insider/0001412377","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18500.0,"shares_display":"18,500","price_per_share":1.0528,"price_display":"1.05","price_state":"stated","total_value":19476.8,"total_display":"19,476.80","total_whole":"19,477","shares_owned_after":28819.0,"shares_owned_after_display":"28,819","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-01-23","filed_date":"2019-01-25","scope":"insider"},{"id":6654787,"accession":"0001144204-18-050779","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-18-050779","line_url":"/filing/0001144204-18-050779#line-1","is_derivative":false,"issuer_cik":"0000910267","issuer_name":"TITAN PHARMACEUTICALS INC","issuer_ticker":"TTNP","issuer_name_source":null,"issuer_url":"/issuer/0000910267","owner_cik":"0001412377","owner_name":"Rubin Marc","owner_display_name":"Rubin Marc","owner_url":"/insider/0001412377","role":"Director, Officer (Executive Chairman)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Chairman","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":400000.0,"shares_display":"400,000","price_per_share":0.25,"price_display":"0.25","price_state":"stated","total_value":100000.0,"total_display":"100,000.00","total_whole":"100,000","shares_owned_after":556317.0,"shares_owned_after_display":"556,317","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-09-21","filed_date":"2018-09-25","scope":"insider"},{"id":6893019,"accession":"0001179022-18-000070","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179022-18-000070","line_url":"/filing/0001179022-18-000070#line-2","is_derivative":false,"issuer_cik":"0001133416","issuer_name":"GALECTIN THERAPEUTICS INC","issuer_ticker":"GALT","issuer_name_source":null,"issuer_url":"/issuer/0001133416","owner_cik":"0001412377","owner_name":"Rubin Marc","owner_display_name":"Rubin Marc","owner_url":"/insider/0001412377","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11900.0,"shares_display":"11,900","price_per_share":6.5761,"price_display":"6.58","price_state":"stated","total_value":78255.59,"total_display":"78,255.59","total_whole":"78,256","shares_owned_after":20581.0,"shares_owned_after_display":"20,581","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-09-04","filed_date":"2018-09-06","scope":"insider"},{"id":6391190,"accession":"0001179022-18-000069","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179022-18-000069","line_url":"/filing/0001179022-18-000069#line-2","is_derivative":false,"issuer_cik":"0001133416","issuer_name":"GALECTIN THERAPEUTICS INC","issuer_ticker":"GALT","issuer_name_source":null,"issuer_url":"/issuer/0001133416","owner_cik":"0001412377","owner_name":"Rubin Marc","owner_display_name":"Rubin Marc","owner_url":"/insider/0001412377","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":58100.0,"shares_display":"58,100","price_per_share":6.0811,"price_display":"6.08","price_state":"stated","total_value":353311.91,"total_display":"353,311.91","total_whole":"353,312","shares_owned_after":26481.0,"shares_owned_after_display":"26,481","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-08-30","filed_date":"2018-09-04","scope":"insider"},{"id":9238348,"accession":"0001179022-17-000071","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179022-17-000071","line_url":"/filing/0001179022-17-000071#line-1","is_derivative":false,"issuer_cik":"0001412377","issuer_name":"GALECTIN THERAPEUTICS INC","issuer_ticker":"GALT","issuer_name_source":null,"issuer_url":"/issuer/0001412377","owner_cik":"0001412377","owner_name":"Rubin Marc","owner_display_name":"Rubin Marc","owner_url":"/insider/0001412377","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":7000.0,"shares_display":"7,000","price_per_share":1.8531,"price_display":"1.85","price_state":"stated","total_value":12971.7,"total_display":"12,971.70","total_whole":"12,972","shares_owned_after":55581.0,"shares_owned_after_display":"55,581","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-12-08","filed_date":"2017-12-08","scope":"insider"},{"id":4409463,"accession":"0001179022-17-000069","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179022-17-000069","line_url":"/filing/0001179022-17-000069#line-1","is_derivative":false,"issuer_cik":"0001133416","issuer_name":"GALECTIN THERAPEUTICS INC","issuer_ticker":"GALT","issuer_name_source":null,"issuer_url":"/issuer/0001133416","owner_cik":"0001412377","owner_name":"Rubin Marc","owner_display_name":"Rubin Marc","owner_url":"/insider/0001412377","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":7000.0,"shares_display":"7,000","price_per_share":1.8531,"price_display":"1.85","price_state":"stated","total_value":12971.7,"total_display":"12,971.70","total_whole":"12,972","shares_owned_after":55581.0,"shares_owned_after_display":"55,581","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-12-08","filed_date":"2017-12-08","scope":"insider"},{"id":4494206,"accession":"0001209191-17-061106","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-061106","line_url":"/filing/0001209191-17-061106#line-1","is_derivative":false,"issuer_cik":"0001108205","issuer_name":"CURIS INC","issuer_ticker":"CRIS","issuer_name_source":null,"issuer_url":"/issuer/0001108205","owner_cik":"0001412377","owner_name":"Rubin Marc","owner_display_name":"Rubin Marc","owner_url":"/insider/0001412377","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":25000.0,"shares_display":"25,000","price_per_share":0.98,"price_display":"0.98","price_state":"stated","total_value":24500.0,"total_display":"24,500.00","total_whole":"24,500","shares_owned_after":51596.0,"shares_owned_after_display":"51,596","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-11-16","filed_date":"2017-11-16","scope":"insider"},{"id":3332404,"accession":"0001144204-16-075190","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-16-075190","line_url":"/filing/0001144204-16-075190#line-1","is_derivative":false,"issuer_cik":"0000910267","issuer_name":"TITAN PHARMACEUTICALS INC","issuer_ticker":"TTNP","issuer_name_source":null,"issuer_url":"/issuer/0000910267","owner_cik":"0001412377","owner_name":"Rubin Marc","owner_display_name":"Rubin Marc","owner_url":"/insider/0001412377","role":"Director, Officer (Executive Chairman)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Chairman","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":3.25,"price_display":"3.25","price_state":"stated","total_value":16250.0,"total_display":"16,250.00","total_whole":"16,250","shares_owned_after":156317.0,"shares_owned_after_display":"156,317","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-01-11","filed_date":"2016-01-11","scope":"insider"},{"id":8206696,"accession":"0001144204-15-053051","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-15-053051","line_url":"/filing/0001144204-15-053051#line-1","is_derivative":false,"issuer_cik":"0000910267","issuer_name":"TITAN PHARMACEUTICALS INC","issuer_ticker":"TTNP","issuer_name_source":null,"issuer_url":"/issuer/0000910267","owner_cik":"0001412377","owner_name":"Rubin Marc","owner_display_name":"Rubin Marc","owner_url":"/insider/0001412377","role":"Director, Officer (Executive Chairman)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Chairman","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":50000.0,"shares_display":"50,000","price_per_share":0.715,"price_display":"0.72","price_state":"stated","total_value":35750.0,"total_display":"35,750.00","total_whole":"35,750","shares_owned_after":832200.0,"shares_owned_after_display":"832,200","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-08-28","filed_date":"2015-08-31","scope":"insider"},{"id":6806277,"accession":"0001144204-14-060881","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-14-060881","line_url":"/filing/0001144204-14-060881#line-1","is_derivative":false,"issuer_cik":"0000910267","issuer_name":"TITAN PHARMACEUTICALS INC","issuer_ticker":"TTNP.OB","issuer_name_source":null,"issuer_url":"/issuer/0000910267","owner_cik":"0001412377","owner_name":"Rubin Marc","owner_display_name":"Rubin Marc","owner_url":"/insider/0001412377","role":"Director, Officer (Executive Chairman)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Chairman","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100000.0,"shares_display":"100,000","price_per_share":0.482,"price_display":"0.48","price_state":"stated","total_value":48200.0,"total_display":"48,200.00","total_whole":"48,200","shares_owned_after":707200.0,"shares_owned_after_display":"707,200","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-10-09","filed_date":"2014-10-14","scope":"insider"},{"id":4380820,"accession":"0000914062-13-000367","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000914062-13-000367","line_url":"/filing/0000914062-13-000367#line-1","is_derivative":false,"issuer_cik":"0001133416","issuer_name":"GALECTIN THERAPEUTICS INC","issuer_ticker":"GALT","issuer_name_source":null,"issuer_url":"/issuer/0001133416","owner_cik":"0001412377","owner_name":"Rubin Marc","owner_display_name":"Rubin Marc","owner_url":"/insider/0001412377","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3000.0,"shares_display":"3,000","price_per_share":8.69,"price_display":"8.69","price_state":"stated","total_value":26070.0,"total_display":"26,070.00","total_whole":"26,070","shares_owned_after":6334.0,"shares_owned_after_display":"6,334","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-12-04","filed_date":"2013-12-04","scope":"insider"},{"id":5292695,"accession":"0001181431-13-035718","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-13-035718","line_url":"/filing/0001181431-13-035718#line-1","is_derivative":false,"issuer_cik":"0000910267","issuer_name":"TITAN PHARMACEUTICALS INC","issuer_ticker":"TTNP.OB","issuer_name_source":null,"issuer_url":"/issuer/0000910267","owner_cik":"0001412377","owner_name":"Rubin Marc","owner_display_name":"Rubin Marc","owner_url":"/insider/0001412377","role":"Director, Officer (Executive Chairman)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Chairman","security_title":"Common Stock, $0.001 par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":50000.0,"shares_display":"50,000","price_per_share":0.4538,"price_display":"0.45","price_state":"stated","total_value":22690.0,"total_display":"22,690.00","total_whole":"22,690","shares_owned_after":463400.0,"shares_owned_after_display":"463,400","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-06-17","filed_date":"2013-06-19","scope":"insider"},{"id":9009496,"accession":"0001209191-11-057409","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-11-057409","line_url":"/filing/0001209191-11-057409#line-1","is_derivative":false,"issuer_cik":"0000910267","issuer_name":"TITAN PHARMACEUTICALS INC","issuer_ticker":"TTNP.OB","issuer_name_source":null,"issuer_url":"/issuer/0000910267","owner_cik":"0001412377","owner_name":"Rubin Marc","owner_display_name":"Rubin Marc","owner_url":"/insider/0001412377","role":"Director, Officer (Executive Chairman)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Chairman","security_title":"Common Stock, $0.001 par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":38400.0,"shares_display":"38,400","price_per_share":1.2739,"price_display":"1.27","price_state":"stated","total_value":48917.76,"total_display":"48,917.76","total_whole":"48,918","shares_owned_after":413400.0,"shares_owned_after_display":"413,400","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-11-18","filed_date":"2011-11-21","scope":"insider"},{"id":8978833,"accession":"0001209191-11-052256","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-11-052256","line_url":"/filing/0001209191-11-052256#line-1","is_derivative":false,"issuer_cik":"0001133416","issuer_name":"GALECTIN THERAPEUTICS INC","issuer_ticker":"GALT.OB","issuer_name_source":null,"issuer_url":"/issuer/0001133416","owner_cik":"0001412377","owner_name":"Rubin Marc","owner_display_name":"Rubin Marc","owner_url":"/insider/0001412377","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":0.96,"price_display":"0.96","price_state":"stated","total_value":19200.0,"total_display":"19,200.00","total_whole":"19,200","shares_owned_after":20000.0,"shares_owned_after_display":"20,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-10-18","filed_date":"2011-10-20","scope":"insider"},{"id":7667938,"accession":"0001181431-10-061465","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-10-061465","line_url":"/filing/0001181431-10-061465#line-1","is_derivative":false,"issuer_cik":"0001108205","issuer_name":"CURIS INC","issuer_ticker":"CRIS","issuer_name_source":null,"issuer_url":"/issuer/0001108205","owner_cik":"0001412377","owner_name":"Rubin Marc","owner_display_name":"Rubin Marc","owner_url":"/insider/0001412377","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":26596.0,"shares_display":"26,596","price_per_share":1.89,"price_display":"1.89","price_state":"stated","total_value":50266.44,"total_display":"50,266.44","total_whole":"50,266","shares_owned_after":26596.0,"shares_owned_after_display":"26,596","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-12-10","filed_date":"2010-12-14","scope":"insider"},{"id":3131461,"accession":"0001181431-08-008437","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001181431-08-008437","line_url":"/filing/0001181431-08-008437","is_derivative":false,"issuer_cik":"0000910267","issuer_name":"TITAN PHARMACEUTICALS INC","issuer_ticker":"AMEX-TTP","issuer_name_source":null,"issuer_url":"/issuer/0000910267","owner_cik":"0001412377","owner_name":"Rubin Marc","owner_display_name":"Rubin Marc","owner_url":"/insider/0001412377","role":"Director, Officer (President & Chief Ex Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & Chief Ex Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":1.30282,"price_display":"1.30","price_state":"stated","total_value":6514.1,"total_display":"6,514.10","total_whole":"6,514","shares_owned_after":129250.0,"shares_owned_after_display":"129,250","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-02-07","filed_date":"2008-02-07","scope":"insider","n_lines":2},{"id":3131453,"accession":"0001181431-08-008437","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001181431-08-008437","line_url":"/filing/0001181431-08-008437","is_derivative":false,"issuer_cik":"0000910267","issuer_name":"TITAN PHARMACEUTICALS INC","issuer_ticker":"AMEX-TTP","issuer_name_source":null,"issuer_url":"/issuer/0000910267","owner_cik":"0001412377","owner_name":"Rubin Marc","owner_display_name":"Rubin Marc","owner_url":"/insider/0001412377","role":"Director, Officer (President & Chief Ex Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & Chief Ex Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":15000.0,"shares_display":"15,000","price_per_share":1.3133333333333332,"price_display":"1.31","price_state":"stated","total_value":19700.0,"total_display":"19,700.00","total_whole":"19,700","shares_owned_after":115000.0,"shares_owned_after_display":"115,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-02-06","filed_date":"2008-02-07","scope":"insider","n_lines":3},{"id":3131441,"accession":"0001181431-08-008437","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-08-008437","line_url":"/filing/0001181431-08-008437#line-1","is_derivative":false,"issuer_cik":"0000910267","issuer_name":"TITAN PHARMACEUTICALS INC","issuer_ticker":"AMEX-TTP","issuer_name_source":null,"issuer_url":"/issuer/0000910267","owner_cik":"0001412377","owner_name":"Rubin Marc","owner_display_name":"Rubin Marc","owner_url":"/insider/0001412377","role":"Director, Officer (President & Chief Ex Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & Chief Ex Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":1.38,"price_display":"1.38","price_state":"stated","total_value":13800.0,"total_display":"13,800.00","total_whole":"13,800","shares_owned_after":110000.0,"shares_owned_after_display":"110,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-02-05","filed_date":"2008-02-07","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":24,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":18,"open_market":true},{"code":"S","label":"Open-market sale","n":6,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":24},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001133416","name":"GALECTIN THERAPEUTICS INC","url":"/issuer/0001133416","role":"Director","n_filings":7,"first_seen":"2011-10-20","last_seen":"2019-02-25"},{"type":"issuer","type_label":"ISSUER","cik":"0001108205","name":"CURIS INC","url":"/issuer/0001108205","role":"Director","n_filings":3,"first_seen":"2010-12-14","last_seen":"2019-01-25"},{"type":"issuer","type_label":"ISSUER","cik":"0000910267","name":"TITAN PHARMACEUTICALS INC","url":"/issuer/0000910267","role":"Director, Officer (Executive Chairman)","n_filings":7,"first_seen":"2008-02-07","last_seen":"2018-09-25"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001412377","retrieved_at":"2026-08-24T18:44:12+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}